Upstream Bio (UPB) news
Recent news
CPBIO renewal of continuing connected transactions, notice of special general meeting
Cancer Prevention & Biotechnology Limited (CPBIO) has announced the renewal of its continuing connected transactions, as disclosed in a recent regulatory filing. The company has also issued a notice of a special general meeting (SGM) to be held on October 30, 2026, for shareholders to consider and…
AInvest Wire · 1d agoCPBIO renewal of continuing connected transactions, notice of special general meeting
AInvest Wire · 1d agoUpstream Bio, - Remains on track to initiate phase 3 trials in severe asthma and CRSWNP in Q1 2027
Upstream Bio, Inc. (Nasdaq: UPB) remains on track to initiate Phase 3 clinical trials for verekitug in both severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) in the first quarter of 2027, as previously announced. The company has finalized its Phase 3 development strategy following…
AInvest Wire · Sep 8, 2026Upstream Bio, - expects BLA submission for Verekitug with potential launch as early as 2030
AInvest Wire · Sep 1, 2026Upstream Bio, - To initiate phase 3 trials in Q1 2027
AInvest Wire · Sep 1, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.